Coronavirus: how and when will the Pfizer vaccine be rolled out to millions of Brits?
Matt Hancock says NHS will be ready to administer doses to vulnerable people from 1 December
The NHS will be ready to begin inoculating millions of people against Covid-19 with the breakthrough Pfizer vaccine within weeks, the health secretary has told MPs.
Matt Hancock said the health service would begin rolling out a mass vaccination programme from 1 December if the jab is approved for use in the UK.
But he warned “there are no guarantees” that the vaccine will end the crisis quickly, adding: “We don’t know what proportion of the population vaccination needs to reach in order for this to stop the epidemic.”
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
How will it be rolled out?
German firm Pfizer raised hopes worldwide on Monday by announcing that the first interim results in large-scale trials had found its coronavirus vaccine to be 90% effective.
Hancock told the Commons yesterday that Britain has purchased 40 million doses of the vaccine - enough to innoculate 20 million people, each of whom needs to receive two doses, given 21 days apart, for the jabs to be effective. The Telegraph reports that ten million of these doses are “due to be delivered by the end of this year, as long as regulatory approval is granted”.
NHS England and the British Medical Association have agreed that family doctors should “play the lead role” in the vaccination drive, which will be of “a scale and complexity” unprecedented in the health service’s long history, says The Guardian.
This drive - described by Hancock as a “mammoth logistical operation” - will see GP services reduced well into 2021 “so family doctors can immunise millions of people against coronavirus at new seven-day-a-week clinics”, the paper adds.
GPs will also recieve an extra £150m in funding to help with the rollout.
Who will be first up?
Although the health service is preparing to begin the vaccination programme at the start of December, Hancock said that the bulk of the rollout was always expected to be “in the first part of 2021”, the BBC reports.
Certain high-risk groups will be prioritised in the initial rollout.
After analysing data to determine which groups suffer the worst outcomes from Covid-19 and which are at highest risk of death, the Joint Committee on Vaccination and Immunisation (JCVI) has issued interim guidance that says the order of priority should be:
1. Older adults in a care home and care home workers2. All those aged 80 and over3. Anyone 75 and over4. People aged 70 and over5. All those aged 65 and over6. High-risk adults under 657. Moderate-risk adults under 658. All those aged 60 and over9. All those 55 and over10. All those aged 50 and over11. The rest of the population, with priority yet to be determined.
Current government guidance states that “whether health and social care workers should be prioritised above, alongside, or below, persons at highest risk” from the virus would “depend on the characteristics of the vaccines when they become available and the epidemiology of disease at the time of delivery”.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Drugmakers paid pharmacy benefit managers to avoid restricting opioid prescriptions
Under the radar The middlemen and gatekeepers of insurance coverage have been pocketing money in exchange for working with Big Pharma
By Theara Coleman, The Week US Published
-
The week's best photos
In Pictures A cyclone's aftermath, a fearless leap, and more
By Anahi Valenzuela, The Week US Published
-
The Imaginary Institution of India: a 'compelling' exhibition
The Week Recommends 'Vibrant' show at the Barbican examines how political upheaval stimulated Indian art
By The Week UK Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Last updated
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published